Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:EWG NASDAQ:SLS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEWGiShares MSCI Germany ETF$41.56+0.8%$42.16$37.97▼$44.65$1.67B0.952.01 million shs256,735 shsSLSSELLAS Life Sciences Group$13.22+4.8%$9.14$1.39▼$15.88$2.62B2.428.55 million shs2.89 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEWGiShares MSCI Germany ETF-0.63%-3.35%-2.55%-2.28%-2.87%SLSSELLAS Life Sciences Group-1.10%-9.47%+61.17%+159.67%+585.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEWGiShares MSCI Germany ETF$41.56+0.8%$42.16$37.97▼$44.65$1.67B0.952.01 million shs256,735 shsSLSSELLAS Life Sciences Group$13.22+4.8%$9.14$1.39▼$15.88$2.62B2.428.55 million shs2.89 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEWGiShares MSCI Germany ETF-0.63%-3.35%-2.55%-2.28%-2.87%SLSSELLAS Life Sciences Group-1.10%-9.47%+61.17%+159.67%+585.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEWGiShares MSCI Germany ETF 0.00N/AN/AN/ASLSSELLAS Life Sciences Group 2.33Hold$10.00-20.76% DownsideCurrent Analyst Ratings BreakdownLatest MGCI, EWG, SLS, and IIG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/6/2026SLSSELLAS Life Sciences Group Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy4/21/2026SLSSELLAS Life Sciences Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEWGiShares MSCI Germany ETFN/AN/AN/AN/AN/AN/ASLSSELLAS Life Sciences GroupN/AN/AN/AN/A$0.46 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEWGiShares MSCI Germany ETFN/AN/A17.79N/AN/AN/AN/AN/AN/ASLSSELLAS Life Sciences Group-$26.86M-$0.23N/AN/AN/AN/A-47.12%-42.63%8/11/2026 (Estimated)Latest MGCI, EWG, SLS, and IIG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026Q2 2026SLSSELLAS Life Sciences Group-$0.0450N/AN/AN/AN/AN/A5/12/2026Q1 2026SLSSELLAS Life Sciences Group-$0.06-$0.05+$0.01-$0.05N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEWGiShares MSCI Germany ETF$0.832.00%N/AN/AN/ASLSSELLAS Life Sciences GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEWGiShares MSCI Germany ETFN/AN/AN/ASLSSELLAS Life Sciences GroupN/A17.2217.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEWGiShares MSCI Germany ETF53.42%SLSSELLAS Life Sciences Group17.38%Insider OwnershipCompanyInsider OwnershipEWGiShares MSCI Germany ETFN/ASLSSELLAS Life Sciences Group1.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEWGiShares MSCI Germany ETFN/A40.20 millionN/ANot OptionableSLSSELLAS Life Sciences Group10196.63 million194.08 millionNot OptionableCMPI, SLS, EWG, and TRG HeadlinesRecent News About These CompaniesInvestors Purchase High Volume of Call Options on SELLAS Life Sciences Group (NASDAQ:SLS)July 13 at 1:39 PM | marketbeat.comSellas Life Sciences: REGAL Trial's Delayed Events Signal Selection BiasJuly 9, 2026 | seekingalpha.comHere’s Why SELLAS (SLS) is Among the 10 Best Performing American Stocks in June 2026July 9, 2026 | finance.yahoo.comSLS stock in the spotlight as CEO pushes back on Regal trial criticism – 'Let's separate the noise from the data'July 8, 2026 | msn.comMost and least shorted mid- to mega-cap healthcare stocks at the end of JuneJuly 1, 2026 | seekingalpha.comSELLAS Life Sciences Group (SLS) Stock Looks Above Fair Value Before Key Trial DataJuly 1, 2026 | finance.yahoo.comDoes SELLAS (SLS) Executive Severance Reset Hint at M&A Readiness or Standalone Ambition?June 30, 2026 | uk.finance.yahoo.comWhy Sellas Remains A Strong Sell After Doubling In PriceJune 30, 2026 | seekingalpha.comSELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move?June 30, 2026 | benzinga.comSellas Life (SLS) Climbs to Record High on Acquisition BuzzJune 30, 2026 | finance.yahoo.comSellas Life Sciences shares break out to new 52-week high: What's driving the momentum?June 29, 2026 | msn.comIs SELLAS Life Sciences Group, Inc. (SLS) A Good Stock To Buy Now?June 29, 2026 | insidermonkey.comWhy did SLS, MRNA, ABCL stocks surge to 52-week highs last week?June 28, 2026 | msn.comSellas Life Sciences: The AML Platform Is More Interesting Than The Binary EventJune 27, 2026 | seekingalpha.comSELLAS Life Sciences jumps as traders focus on imminent REGAL trial catalyst and stronger cash positionJune 26, 2026 | quiverquant.comQSELLAS stock hits new highs: What's happening today?June 26, 2026 | msn.comWhat's driving SLS stock higher today and what comes next?June 26, 2026 | invezz.comISLS Short Interest Hits All-Time High: Sellas Bulls Smell A Short Squeeze As Executive Contract Changes Fuel Buyout ChatterJune 26, 2026 | finance.yahoo.comSellas (SLS) Extends Rally, New Filing Hints at Company TakeoverJune 26, 2026 | insidermonkey.comSLS stock up 13% as executive severance updates reignite buyout speculationJune 25, 2026 | msn.comSLS stock slips overnight: Shareholders approve 20M new shares, CEO awarded 1M RSUsJune 22, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCMPI, SLS, EWG, and TRG Company DescriptionsiShares MSCI Germany ETF NYSEARCA:EWG$41.56 +0.33 (+0.80%) As of 12:40 PM EasterniShares MSCI Germany ETF, formerly iShares MSCI Germany Index Fund (the Fund), is an exchange-traded fund. The Fund seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of publicly traded securities in the German market, as measured by the MSCI Germany Index (the Index). The Index seeks to measure the performance of the Germany equity market. It is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. The Fund invests in sectors, such as consumer discretionary, financials, materials, industrials, healthcare, information technology, utilities, telecommunication services and consumer staples. BlackRock Fund Advisors (BFA) serves as the investment adviser to the Fund.SELLAS Life Sciences Group NASDAQ:SLS$13.22 +0.60 (+4.76%) As of 12:58 PM Eastern This is a fair market value price provided by Massive. Learn more.SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Energy Stocks Racing to Fix AI's Power Problem No Space For Panic: T-Mobile Shrugs Off The Starlink Threat Prepare for the Next Wave of Factory Automation With These 3 Standout Names Wedbush Pounds the Table—Buy Sandisk Before August 5 Earnings The Bond Market Just Sent Amazon a Message Investors Shouldn’t Ignore Insiders Sell 2 AI Enablers: Investors Can Buy Into Their Futures These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending These 3 Stocks Are Beating the Market in 2026 and Just Announced Hefty Dividend Increases Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
